The effects of formoterol/budesonide on sleep quality of COPD patients

G. Sagcan, U. Memis, C. Cuhadaroglu, C. Sen, E. Duygu (Istanbul, Turkey)

Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Session: Sleep apnoea in cardiorespiratory disorders
Session type: Electronic Poster Discussion
Number: 3049
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Sagcan, U. Memis, C. Cuhadaroglu, C. Sen, E. Duygu (Istanbul, Turkey). The effects of formoterol/budesonide on sleep quality of COPD patients. Eur Respir J 2007; 30: Suppl. 51, 3049

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Poor sleep quality in COPD: related factors and its effects on COPD patients
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009


The influence of fenspiride in complex therapy on quality of life in COPD patients
Source: Annual Congress 2010 - COPD: management
Year: 2010


Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Frequency of bronchiectasis in patients with COPD and effects on quality of life
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009


Effect of nCPAP on quality of life (QoL) in professionally active patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 113s
Year: 2005

Health related quality of life after CPAP treatment in patients with obstructive sleep apnoea and patients with overlap syndrome
Source: Eur Respir J 2003; 22: Suppl. 45, 468s
Year: 2003

Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016


Cognition, quality of life and adherence to CPAP after 18-months treatment in obstructive sleep apnea patients
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011

Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013

Nighttime symptoms and reduced quality of life among COPD patients
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012

Effects of nCPAP treatment on quality of life of patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 410s
Year: 2006

The effect of sleep-related intervention on the quality of life in pulmonary patients
Source: Eur Respir J 2001; 18: Suppl. 33, 420s
Year: 2001

Comparison of fatigue and sleep quality between COPD and healthy subjects
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma
Year: 2013


NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011


Automatic CPAP performance in sleep apnea patients with associated COPD
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Source: Eur Respir J 2002; 19: 209-216
Year: 2002



Impact of sleep quality and comorbidities on health-related quality of life in patients with obstructive sleep apnea
Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Year: 2019


QVA149 is more efficacious than tiotropium and salmeterol/fluticasone combination (SFC) in improving patient-reported outcomes and lung function in COPD patients with moderate-to-severe baseline dyspnoea: The IGNITE trials
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015

The effect of CPAP in asthma patients with SAHS
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


Effect of upper airway stimulation for quality of life and sleep architecture in patients with moderate-to-severe OSA
Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea
Year: 2011